Dipeptidyl Peptidase-4 Inhibitors and the Risk of Chronic Inflammatory Skin Diseases in Type 2 Diabetes Mellitus in Taiwan: A Nationwide Population-Based Cohort Study.

J Invest Dermatol

Department of Dermatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan; School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan. Electronic address:

Published: October 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2024.03.017DOI Listing

Publication Analysis

Top Keywords

dipeptidyl peptidase-4
4
peptidase-4 inhibitors
4
inhibitors risk
4
risk chronic
4
chronic inflammatory
4
inflammatory skin
4
skin diseases
4
diseases type
4
type diabetes
4
diabetes mellitus
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!